India, Feb. 13 -- What kind of policy reforms are you looking at to revolutionise the CRO sector?

I believe the most meaningful reform would be to make the approval process for clinical research more predictable. Over the last several years, we have made significant progress in harmonising our processes with those followed in other countries. Some distance has been covered, but more still needs to be done. Global research ecosystem demands is predictive timeframe over uncertainty and surprises. Most global companies conduct multinational studies, and once trials begin in other countries, they cannot wait indefinitely. It is heartening to see progress towards a more defined and clear approval timelines, transparent tracking, harmonization...